FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2088229247> ?p ?o ?g. }

• W2088229247 endingPage "760" @default.
• W2088229247 startingPage "759" @default.
• W2088229247 abstract "Myotubular myopathy (MTM) is a severe congenital myopathy with no currently identified treatment. MTM is caused by mutations in MTM1, a phosphatase that dephosphorylates 3-position phosphoinositides. Through the use of vertebrate model systems, the consequences (s) of MTM1 mutation in skeletal muscle in vivo are beginning to be unraveled. In particular, work from several laboratories (including our own) has demonstrated that loss of MTM1 (1) increases the levels of PI3P in skeletal muscle and (2) results in the disruption of the structure and function of the EC coupling apparatus. Based on these data, one hypothesis to explain MTM is that pathologic elevation of PI3P results in aberrant EC coupling, which in turn causes muscle weakness and severe neurologic disability. A correlate hypothesis is that lowering PI3P levels in MTM will enable normal muscle structure and will thus ameliorate the disease. These hypotheses lead to 2 critical questions: What is the consequence of reducing PI3P levels on normal skeletal muscle development? What is the impact of reducing PI3P levels on MTM pathogenesis? The goal of this study is to address these questions by studying models with reduced PI3P. We have created knockout mice that lack either Pik3c2b or Pik3c3, the kinases responsible for PI3P production in skeletal muscle. Using these animals, we have identified unique and non-overlapping functions for these kinases, including the observation that loss of Pik3c3 results in a muscular dystrophy phenotype. Furthermore, we have tested the concept of PI3P reduction as a therapeutic strategy for MTM by crossbreeding individual kinase knockouts with Mtm1 knockouts. Preliminary data shows that reduced expression of one of the kinases significantly improves the Mtm1 phenotype. In all, our data reveals for the first time the role of 3-PI kinases in skeletal muscle, and identifies a potential therapeutic target for the treatment of MTM. Myotubular myopathy (MTM) is a severe congenital myopathy with no currently identified treatment. MTM is caused by mutations in MTM1, a phosphatase that dephosphorylates 3-position phosphoinositides. Through the use of vertebrate model systems, the consequences (s) of MTM1 mutation in skeletal muscle in vivo are beginning to be unraveled. In particular, work from several laboratories (including our own) has demonstrated that loss of MTM1 (1) increases the levels of PI3P in skeletal muscle and (2) results in the disruption of the structure and function of the EC coupling apparatus. Based on these data, one hypothesis to explain MTM is that pathologic elevation of PI3P results in aberrant EC coupling, which in turn causes muscle weakness and severe neurologic disability. A correlate hypothesis is that lowering PI3P levels in MTM will enable normal muscle structure and will thus ameliorate the disease. These hypotheses lead to 2 critical questions: What is the consequence of reducing PI3P levels on normal skeletal muscle development? What is the impact of reducing PI3P levels on MTM pathogenesis? The goal of this study is to address these questions by studying models with reduced PI3P. We have created knockout mice that lack either Pik3c2b or Pik3c3, the kinases responsible for PI3P production in skeletal muscle. Using these animals, we have identified unique and non-overlapping functions for these kinases, including the observation that loss of Pik3c3 results in a muscular dystrophy phenotype. Furthermore, we have tested the concept of PI3P reduction as a therapeutic strategy for MTM by crossbreeding individual kinase knockouts with Mtm1 knockouts. Preliminary data shows that reduced expression of one of the kinases significantly improves the Mtm1 phenotype. In all, our data reveals for the first time the role of 3-PI kinases in skeletal muscle, and identifies a potential therapeutic target for the treatment of MTM." @default.
• W2088229247 created "2016-06-24" @default.
• W2088229247 creator A5007215283 @default.
• W2088229247 creator A5038663582 @default.
• W2088229247 creator A5054762297 @default.
• W2088229247 creator A5056586273 @default.
• W2088229247 creator A5090827521 @default.
• W2088229247 date "2013-10-01" @default.
• W2088229247 modified "2023-09-27" @default.
• W2088229247 title "P.4.1 PIP kinases, muscle development, and the pathogenesis of myotubular myopathy" @default.
• W2088229247 doi "https://doi.org/10.1016/j.nmd.2013.06.439" @default.
• W2088229247 hasPublicationYear "2013" @default.
• W2088229247 type Work @default.
• W2088229247 sameAs 2088229247 @default.
• W2088229247 citedByCount "0" @default.
• W2088229247 crossrefType "journal-article" @default.
• W2088229247 hasAuthorship W2088229247A5007215283 @default.
• W2088229247 hasAuthorship W2088229247A5038663582 @default.
• W2088229247 hasAuthorship W2088229247A5054762297 @default.
• W2088229247 hasAuthorship W2088229247A5056586273 @default.
• W2088229247 hasAuthorship W2088229247A5090827521 @default.
• W2088229247 hasConcept C104317684 @default.
• W2088229247 hasConcept C126322002 @default.
• W2088229247 hasConcept C127716648 @default.
• W2088229247 hasConcept C134018914 @default.
• W2088229247 hasConcept C184235292 @default.
• W2088229247 hasConcept C203014093 @default.
• W2088229247 hasConcept C2775934546 @default.
• W2088229247 hasConcept C2777300911 @default.
• W2088229247 hasConcept C2779438767 @default.
• W2088229247 hasConcept C2779959927 @default.
• W2088229247 hasConcept C2779999465 @default.
• W2088229247 hasConcept C2780942790 @default.
• W2088229247 hasConcept C54355233 @default.
• W2088229247 hasConcept C71924100 @default.
• W2088229247 hasConcept C86803240 @default.
• W2088229247 hasConceptScore W2088229247C104317684 @default.
• W2088229247 hasConceptScore W2088229247C126322002 @default.
• W2088229247 hasConceptScore W2088229247C127716648 @default.
• W2088229247 hasConceptScore W2088229247C134018914 @default.
• W2088229247 hasConceptScore W2088229247C184235292 @default.
• W2088229247 hasConceptScore W2088229247C203014093 @default.
• W2088229247 hasConceptScore W2088229247C2775934546 @default.
• W2088229247 hasConceptScore W2088229247C2777300911 @default.
• W2088229247 hasConceptScore W2088229247C2779438767 @default.
• W2088229247 hasConceptScore W2088229247C2779959927 @default.
• W2088229247 hasConceptScore W2088229247C2779999465 @default.
• W2088229247 hasConceptScore W2088229247C2780942790 @default.
• W2088229247 hasConceptScore W2088229247C54355233 @default.
• W2088229247 hasConceptScore W2088229247C71924100 @default.
• W2088229247 hasConceptScore W2088229247C86803240 @default.
• W2088229247 hasIssue "9-10" @default.
• W2088229247 hasLocation W20882292471 @default.
• W2088229247 hasOpenAccess W2088229247 @default.
• W2088229247 hasPrimaryLocation W20882292471 @default.
• W2088229247 hasRelatedWork W1482401166 @default.
• W2088229247 hasRelatedWork W1983045080 @default.
• W2088229247 hasRelatedWork W199002553 @default.
• W2088229247 hasRelatedWork W2075596745 @default.
• W2088229247 hasRelatedWork W2110898288 @default.
• W2088229247 hasRelatedWork W2146735843 @default.
• W2088229247 hasRelatedWork W2154646563 @default.
• W2088229247 hasRelatedWork W2619871486 @default.
• W2088229247 hasRelatedWork W3194827698 @default.
• W2088229247 hasRelatedWork W4286588296 @default.
• W2088229247 hasVolume "23" @default.
• W2088229247 isParatext "false" @default.
• W2088229247 isRetracted "false" @default.
• W2088229247 magId "2088229247" @default.
• W2088229247 workType "article" @default.